MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Incorporating Specialist Independent Prescribing Pharmacist (SIPP) sessions into the Movement Disorder Service

D. Fletcher, E. Thomas, B. Mohamed (Cardiff, United Kingdom)

Meeting: 2017 International Congress

Abstract Number: 1318

Keywords: Multidisciplinary Approach, Parkinsonism, Pharmacotherapy

Session Information

Date: Thursday, June 8, 2017

Session Title: Other

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: To describe the incorporation of a prescribing pharmacist into a Multi-disciplinary Parkinson’s clinic based in a University Hospital

Background: Evidence shows that a multidisciplinary approach to disease management offers the most holistic, patient-centred care for People with Parkinson’s(PwP).  Whilst medical, nursing, physiotherapy and occupational therapy are fairly standard MDT members, there are relatively few services locally who have embedded pharmacy specialism in their PD service.

Methods: For a year, a senior pharmacist joined the PD team in a training role during which she developed clinical skills and knowledge relating to diagnosis and management of PD, and at the end of which she achieved Independent Prescriber status.  Following this, the SIPP integrated into the clinic and developed a structured consultation pro forma, using this to independently consult PwP with a focus on their Parkinson’s-related medications.  Through team reflection and patient feedback we obtained qualitative data on the perception of this new role

Results: Patient feedback was overwhelmingly positive and all felt that their general care had been enhanced by having a least one consultation with a strong focus on medication review.  Team reflection was similar, with all agreeing that this role brought a helpful new dimension to the holistic management for People with Parkinson’s.

Conclusions: A number of additional benefits ensued such as an enhanced relationship with the pharmacy department which facilitated i) the development of a Health Board Guideline for management of Parkinson’s in inpatients and ii)improved access to medicines information queries.  The structured consultation provides consistency and uniformity to medicines reviews in Parkinson’s.  We conclude that the addition of a pharmacist to the Parkinson’s MDT enhances the care offered to PwP

To cite this abstract in AMA style:

D. Fletcher, E. Thomas, B. Mohamed. Incorporating Specialist Independent Prescribing Pharmacist (SIPP) sessions into the Movement Disorder Service [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/incorporating-specialist-independent-prescribing-pharmacist-sipp-sessions-into-the-movement-disorder-service/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/incorporating-specialist-independent-prescribing-pharmacist-sipp-sessions-into-the-movement-disorder-service/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley